Journal profile

European heart journal. Cardiovascular pharmacotherapy

Publisher: Oxford University Press
ISSN2055-6837 | 2055-6845 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.85
Citation rate 4.90 936 total citations
h5-index 38 h5 depth signal
Cited share 76.1% 150 of 197
Total citations 936 Citation footprint
Metric signal 5.32 External metric anchor
Self-citation 13.7% 128 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

Italy 241
United States 204
United Kingdom 167
Sweden 140
Germany 117

Citing Fields of Research

Cardiology 726
Diabetes 142
Lipids 79
Pharmacology & Toxicology 49
Hematology 41

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 994 Articles tracked across the journal lifetime
Indexed publication set 197 150 cited publications
Last 12 months 108 9.0 publications/month
Open access share 100.0% 108 OA publications in the last year
Leading citing country Italy 241 citing publications
Leading citing field Cardiology 726 citing publications
Latest tracked publication 4 November 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v2n1, Jan. 2016-
PubMed
v2n1, Jan. 2016- ; Selected citations only before this date

Research Focus & Classification

Indexed Subjects

Cardiology

Issuing & Sponsoring Bodies

issuing body
European Society of Cardiology. Cardiovascular Pharmacotherapy Working Group

Broad Categories

Cardiology Drug Therapy Pharmacology Vascular Diseases

MeSH Descriptors

Cardiovascular Agents Cardiovascular Diseases

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

03
George Frederick Mkoma, Anders Hviid, Björn Pasternak et al.
Background and Aims: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) improve outcomes in patients with heart failure with reduced ejection fraction (HFrEF), yet the optimal timing of initiation in routine clinical practice remains unc...
05
Mariëlle Scheffer, Willemijn van Maarschalkerwaart, Chaohui Dong et al.
Aims: Heart failure with preserved ejection fraction(HFpEF) is characterized by increased diastolic left ventricular(LV) stiffness resulting from variable contributions of myocardial extracellular matrix(ECM) remodeling and titin-based c...

Bibliographical & Catalog Notes

Also issued online.

Companion publication to: European heart journal.

complemented by (work): European heart journal 0195-668X (DLC)sn 79009215 (OCoLC)5585193.